Molecular evolution and targeted recombination of SARS-CoV-2 in South Korea
Atanas V. Demirev,
Kyuyoung Lee,
Joon-Yong Bae,
Heedo Park,
Sejik Park,
Hyunbeen Kim,
Jungmin Lee,
Junhyung Cho,
Jeong-Sun Yang,
Kyung-Chang Kim,
Joo-Yeon Lee,
Kisoon Kim,
Philippe Lemey,
Man-Seong Park,
Jin Il Kim
Affiliations
Atanas V. Demirev
Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea
Kyuyoung Lee
Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea
Joon-Yong Bae
Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea
Heedo Park
Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea
Sejik Park
Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea
Hyunbeen Kim
Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea
Jungmin Lee
Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea
Junhyung Cho
Division of Emerging Viral Diseases and Vector Research, Center for Infectious Diseases Research, National Institute of Infectious Diseases, Korea National Institute of Health, Osong, Republic of Korea
Jeong-Sun Yang
Division of Emerging Viral Diseases and Vector Research, Center for Infectious Diseases Research, National Institute of Infectious Diseases, Korea National Institute of Health, Osong, Republic of Korea
Kyung-Chang Kim
Division of Emerging Viral Diseases and Vector Research, Center for Infectious Diseases Research, National Institute of Infectious Diseases, Korea National Institute of Health, Osong, Republic of Korea
Joo-Yeon Lee
Center for Infectious Diseases Research, National Institute of Infectious Diseases, Korea National Institute of Health, Osong, Republic of Korea
Kisoon Kim
Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea; Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea
Philippe Lemey
Department of Microbiology, Immunology, and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium
Man-Seong Park
Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea; Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea; Biosafety Center, Korea University College of Medicine, Seoul, Republic of Korea; Corresponding author
Jin Il Kim
Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea; Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea; Biosafety Center, Korea University College of Medicine, Seoul, Republic of Korea; Corresponding author
Summary: SARS-CoV-2 variants have continuously emerged globally, including in South Korea. To characterize the molecular evolution of SARS-CoV-2 in South Korea, we performed phylogenetic and genomic recombination analyses using more than 12,000 complete genome sequences collected until October 2022. The variants in South Korea originated from globally identified variants of concern and harbored genetic clade-common and clade-specific amino acid mutations mainly around the N-terminal domain (NTD) or receptor binding domain (RBD) in the spike protein. Several point mutation residues in key antigenic sites were under positive selection persistently with changing genetic clades of SARS-CoV-2. Furthermore, we detected 17 potential genomic recombinants and 76.4% (13/17) retained the mosaic NTD or RBD genome. Our results suggest that point mutations and genomic recombination in the spike contributed to the molecular evolution of SARS-CoV-2 in South Korea, which will form an integral part of global prevention and control measures against SARS-CoV-2.